enGene Therapeutics: Pay

enGene Therapeutics paid its 3 named executives $11.1M in total in FY2025 (Oct). CEO Ronald H.W. Cooper was paid $5.8M of that.

Pay$100 in the stock at the end of FY24 → $81

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Ronald H.W. CooperChief Executive Officer and President


FY2025 (Oct)
FY2024 (Oct)

2 years

Hussein SweitiChief Medical Officer


FY2025 (Oct)

1 year

Ryan DawsChief Financial Officer


FY2025 (Oct)

1 year

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.